Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ocrelizumab

ocrelizumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Ocrevus INJECTION, INTRAVENOUS 30 mg/mL      


Comments:

Ocrevus medication guide

Restricted to neurology for use in outpatient setting.

Depending on patient's insurance provider, ocrelizumab can be ordered as hospital stock through McKesson Specialty Drug Distribution or as patient specific supply through specialty pharmacy. Reimbursement methods should be evaluated for each patient.


Reviewed: 27 June 2017 (Ocrevus) 


Last updated: Aug. 18, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.